• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Assessing breast tissue density by transillumination breast spectroscopy (TIBS): an intermediate indicator of cancer risk.

作者信息

Blackmore K M, Knight J A, Jong R, Lilge L

机构信息

Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada M5G 2M9.

出版信息

Br J Radiol. 2007 Jul;80(955):545-56. doi: 10.1259/bjr/26858614. Epub 2007 May 30.

DOI:10.1259/bjr/26858614
PMID:17537757
Abstract

Risk assessment by parenchymal density pattern, a strong physical indicator of future breast cancer risk, is available with the onset of mammographic screening programmes. However, due to the use of ionizing radiation, mammography is not recommended for use in younger women, thereby rendering risk assessment unattainable at an earlier age. Visible and near infrared light was used on 292 women with radiologically normal mammograms to determine whether transillumination breast spectroscopy (TIBS) can identify women with a high parenchymal density pattern as an intermediate indicator of breast cancer risk. Principal component analysis (PCA) was used to reduce the spectral data and generate density scores for each woman. To assess the accuracy of TIBS, logistic regression was used to calculate crude and adjusted odds ratios (OR) and 95% confidence intervals (CI) for each score. Receiver operator characteristic (ROC) curves and area under the curve (AUC) were also calculated for the crude and adjusted logistic models. Optical information relating to tissue chromophores, such as water, lipid and haemoglobin content, was sufficient to identify women with high parenchymal density. The resulting AUC for the final and most parsimonious multivariate logistic model was 0.922 (95% CI 0.878-0.967). TIBS provides information correlating to high parenchymal density and is a promising tool for risk assessment, particularly for younger women.

摘要

相似文献

1
Assessing breast tissue density by transillumination breast spectroscopy (TIBS): an intermediate indicator of cancer risk.
Br J Radiol. 2007 Jul;80(955):545-56. doi: 10.1259/bjr/26858614. Epub 2007 May 30.
2
Association between transillumination breast spectroscopy and quantitative mammographic features of the breast.
Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1043-50. doi: 10.1158/1055-9965.EPI-07-2658.
3
Optical transillumination spectroscopy to quantify parenchymal tissue density: an indicator for breast cancer risk.用于量化实质组织密度的光学透照光谱法:一种乳腺癌风险指标。
Br J Radiol. 2005 Nov;78(935):1009-17. doi: 10.1259/bjr/14696165.
4
Non-ionizing near-infrared radiation transillumination spectroscopy for breast tissue density and assessment of breast cancer risk.用于乳腺组织密度和乳腺癌风险评估的非电离近红外辐射透照光谱学
J Biomed Opt. 2004 Jul-Aug;9(4):794-803. doi: 10.1117/1.1758269.
5
Classification of breast tissue density by optical transillumination spectroscopy: optical and physiological effects governing predictive value.
Med Phys. 2004 Jun;31(6):1398-414. doi: 10.1118/1.1738191.
6
Estimation of mammographic density on an interval scale by transillumination breast spectroscopy.
J Biomed Opt. 2008 Nov-Dec;13(6):064030. doi: 10.1117/1.3041498.
7
The association between breast tissue optical content and mammographic density in pre- and post-menopausal women.绝经前和绝经后女性乳腺组织光学成分与乳腺X线密度之间的关联。
PLoS One. 2015 Jan 15;10(1):e0115851. doi: 10.1371/journal.pone.0115851. eCollection 2015.
8
Reassessment of transillumination light scanning for the diagnosis of breast cancer.重新评估透照光扫描在乳腺癌诊断中的应用
Health Technol Assess Rep. 1988(2):1-7.
9
Physical activity and mammographic parenchymal patterns among Greek postmenopausal women.希腊绝经后女性的身体活动与乳腺实质类型。
Maturitas. 2011 May;69(1):74-80. doi: 10.1016/j.maturitas.2011.02.003. Epub 2011 Mar 4.
10
Predicting risk of breast cancer in postmenopausal women by hormone receptor status.根据激素受体状态预测绝经后女性患乳腺癌的风险。
J Natl Cancer Inst. 2007 Nov 21;99(22):1695-705. doi: 10.1093/jnci/djm224. Epub 2007 Nov 13.

引用本文的文献

1
In vivo optimization of the experimental conditions for the non-invasive optical assessment of breast density.在体优化用于无创光学评估乳腺密度的实验条件。
Sci Rep. 2024 Aug 19;14(1):19154. doi: 10.1038/s41598-024-70099-x.
2
Frequency domain diffuse optical spectroscopy with a near-infrared tunable vertical cavity surface emitting laser.采用近红外可调谐垂直腔面发射激光器的频域漫射光学光谱技术。
Opt Express. 2018 Aug 6;26(16):21033-21043. doi: 10.1364/OE.26.021033.
3
Breast density quantification using structured-light-based diffuse optical tomography simulations.
基于结构光的漫射光学层析成像模拟进行乳腺密度定量分析。
Appl Opt. 2017 Sep 1;56(25):7146-7157. doi: 10.1364/AO.56.007146.
4
Imaging Breast Density: Established and Emerging Modalities.乳腺密度成像:既定与新兴模式
Transl Oncol. 2015 Dec;8(6):435-45. doi: 10.1016/j.tranon.2015.10.002.
5
Diffuse Optics for Tissue Monitoring and Tomography.用于组织监测和断层扫描的漫射光学
Rep Prog Phys. 2010 Jul;73(7). doi: 10.1088/0034-4885/73/7/076701.
6
Impact of positional difference on the measurement of breast density using MRI.体位差异对使用MRI测量乳腺密度的影响。
Med Phys. 2015 May;42(5):2268-75. doi: 10.1118/1.4917083.
7
The association between breast tissue optical content and mammographic density in pre- and post-menopausal women.绝经前和绝经后女性乳腺组织光学成分与乳腺X线密度之间的关联。
PLoS One. 2015 Jan 15;10(1):e0115851. doi: 10.1371/journal.pone.0115851. eCollection 2015.
8
Blood flow reduction in breast tissue due to mammographic compression.乳房X线摄影压迫导致乳腺组织血流减少。
Acad Radiol. 2014 Feb;21(2):151-61. doi: 10.1016/j.acra.2013.10.009.
9
Towards non-invasive characterization of breast cancer and cancer metabolism with diffuse optics.利用漫射光学对乳腺癌及癌症代谢进行无创表征
PET Clin. 2013 Jul;8(3). doi: 10.1016/j.cpet.2013.04.004.
10
Assessing tumor contrast in radiographically dense breast tissue using Diffuse Optical Spectroscopic Imaging (DOSI).使用漫射光学光谱成像(DOSI)评估乳腺致密组织中的肿瘤对比度。
Breast Cancer Res. 2013;15(5):R89. doi: 10.1186/bcr3485.